+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
From
Thrombosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Thrombosis Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 387 Pages
  • Global
From
From
From
From
From
Oncologists Market Report 2025 - Product Thumbnail Image

Oncologists Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Autoimmune Drugs - Global Strategic Business Report - Product Thumbnail Image

Autoimmune Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 287 Pages
  • Global
From
Gastrointestinal Diseases Therapeutics Market 2025-2029 - Product Thumbnail Image

Gastrointestinal Diseases Therapeutics Market 2025-2029

  • Report
  • June 2025
  • 215 Pages
  • Global
From
Gene Editing Therapeutics Market - Product Thumbnail Image

Gene Editing Therapeutics Market

  • Report
  • August 2024
  • 111 Pages
  • Global
From
Pharmerging - Global Strategic Business Report - Product Thumbnail Image

Pharmerging - Global Strategic Business Report

  • Report
  • July 2025
  • 184 Pages
  • Global
From
From
From
Loading Indicator